# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Lake Street analyst Frank Takkinen maintains Artivion (NYSE:AORT) with a Buy and raises the price target from $28 to $30.
Stifel analyst Rick Wise maintains Artivion (NYSE:AORT) with a Buy and raises the price target from $22 to $25.
Needham analyst Mike Matson maintains Artivion (NYSE:AORT) with a Buy and raises the price target from $25 to $30.